Catalyst Wire Dossier Catalyst Wire Dossier

Plinabulin

plinabulin · BeyondSpring Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Plinabulin, covering 2019-03-04 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]

See pricing